Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Siemens Healthineers AG    SHL   DE000SHL1006

SIEMENS HEALTHINEERS AG

(SHL)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period September 2018 2019 2020 (e) 2021 (e) 2022 (e)
Sales 13 429 14 518 15 232 16 096 16 969
EBITDA 2 498 2 920 3 030 3 350 3 743
Operating profit (EBIT) 1 968 2 300 2 404 2 731 3 046
Pre-Tax Profit (EBT) 1 799 2 193 2 265 2 588 2 877
Net income 1 265 1 567 1 572 1 820 1 980
P/E ratio 30,1x 23,0x 22,1x 19,2x 17,4x
EPS ( € ) 1,26 1,57 1,61 1,86 2,05
Dividend per Share ( € ) 0,70 0,80 0,87 0,97 1,08
Yield 1,85% 2,22% 2,43% 2,73% 3,02%
Reference price ( € ) 37,875 36,095 35,660 35,660 35,660
Announcement Date 11/05/2018
02:21pm
11/04/2019
12:00am
- - -
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period September 2018 2019 2020 (e) 2021 (e) 2022 (e)
Debt 3 480 3 174 4 470 3 407 2 894
Finance - - - - -
Operating income (EBITDA) 2 498 2 920 3 030 3 350 3 743
Leverage
(Debt/EBITDA)
1,39x 1,09x 1,48x 1,02x 0,77x
Capital Expenditure 530 579 587 580 613
Free Cash Flow (FCF) 1 065 1 038 1 449 1 581 1 830
Book Value Per Share (BVPS) ( € ) 8,53 9,79 10,5 11,4 12,3
Cash Flow per Share ( € ) 1,59 1,62 1,84 2,04 2,10
Announcement Date 11/05/2018
02:21pm
11/04/2019
12:00am
- - -
Balance Sheet Analysis
Financial data source
© 2020 S&P Global Market Intelligence
Financial Ratios

Size 2020e 2021e
Capitalization 35 581 M € -
Entreprise Value (EV) 40 052 M € 38 988 M €
Valuation 2020e 2021e
P/E ratio (Price / EPS) 22,1x 19,2x
Capitalization / Revenue 2,34x 2,21x
EV / Revenue 2,63x 2,49x
EV / EBITDA 13,2x 12,0x
Yield (DPS / Price) 2,43% 2,73%
Price to book (Price / BVPS) 3,39x 3,14x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 15,8% 17,0%
Operating Leverage (Delta EBIT / Delta Sales) 0,92x 2,39x
Net Margin (Net Profit / Revenue) 10,3% 11,3%
ROA (Net Profit / Asset) 7,71% 8,25%
ROE (Net Profit / Equities) 16,6% 17,2%
Rate of Dividend 53,7% 52,3%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   3,86% 3,60%
Cash Flow / Sales 12,1% 12,7%
Capital Intensity (Assets / Sales) 1,34x 1,37x
Financial Leverage (Net Debt / EBITDA) 1,48x 1,02x
EPS & Dividend